Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lucid Lane’s digital health platform delivers evidence-based teletherapy and remote monitoring to help patients safely taper off opioids, benzodiazepines, alcohol or nicotine. The company partners with hospitals and clinics nationwide. Its programs are available in over 35 states and are supported by ongoing peer-reviewed clinical trials at major academic institutions including Stanford University and MD Anderson Cancer Center. The company reports strong growth in patient numbers and revenue since its Series A funding.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lucid Lane.